Senate Republicans Release Draft TSCA Reform Legislation Ahead of EPW Hearing

Senate Republicans have introduced draft Toxic Substances Control Act (TSCA) reform legislation, which will be examined at a Senate Environment and Public Works (EPW) Committee hearing on March 4, 2026.

The “Toxic Substances Control Act Fee Reauthorization and Improvement Act of 2026” takes a narrower approach than its House counterpart released in January, focusing primarily on the regulation of new chemicals under TSCA section 5.  As its title suggests, the discussion draft would also reauthorize the TSCA fee program, which is set to expire at the end of fiscal year 2026, for another 10 years.

“We need to improve our current systems so we can bring better, safer and more innovative chemicals to market — with the predictability and resources to get it right,” EPW Chair Shelley Moore Capito (R-WV) said in a statement to E&E News. “This discussion draft is a step in the right direction, and I look forward to working with my colleagues on this during next week’s hearing.”

Tiered Review for New Chemicals

A central feature of the draft is the creation of a four-tiered framework for new chemical notices under section 5:

  1. Tier 1: New chemicals and new uses that satisfy Safer Choice and Design for the Environment criteria.
  2. Tier 2: New chemicals and new uses that fall into a chemical category “for which the Administrator has developed established scientific methodology for review.”
  3. Tier 3: New chemicals and new uses intended to serve as an alternative to a riskier existing chemical where modeling or other information demonstrates potential risk reduction.
  4. Tier 4: All other new chemicals and new uses.

Although each tier would be assigned its own EPA review timeframe, the draft does not specify the number of review days applicable to any category.  The tiered structure appears designed to address longstanding industry concerns regarding the growing backlog of new chemical submissions, which frequently extend beyond the current statutory 90-day review period (extendable to 180 days).

Third-Party Assessors

Another proposed change presumably designed to address the new chemical submission backlog is a mechanism by which third parties could provide a preliminary review of section 5 submissions.

Accredited third-party assessors would be authorized to review submissions for completeness and determine whether any risk assessment included in the submission was conducted using EPA assumptions, models, and procedures.  Submissions that receive a third-party risk assessment review would be eligible for expedited review periods, which are unspecified but vary by tier.

Notably, if EPA fails to make a determination within the expedited review period for a dual-certified submission—one that received both a completeness and risk assessment review—the applicant would be allowed to commence manufacture consistent with the conditions described in the submission.  EPA would retain authority to order cessation of manufacture upon completing its review.

Stewardship Pathway Authorization

Separate from the tiered review framework, the draft proposes a “stewardship pathway authorization” as an alternative route to the manufacture and distribution of a new chemical.

Applicants would submit a detailed stewardship implementation plan outlining intended conditions of use, engineering controls, disposal practices, PPE requirements, and downstream communication measures.  Manufacturers of chemicals approved under this pathway would be required to obtain contractual commitments from immediate recipients of the substance that they will comply with the approved stewardship implementation plan.  Approved chemicals would not be placed on the TSCA Inventory.

The draft does not specify how many days EPA would have to review stewardship pathway applications.  As with dual-certified third-party submissions, if EPA fails to act before the deadline and no extension has been granted, the requirements of the section would be deemed fulfilled for the conditions of use described in the submission.

Section 5 Exemptions

In addition to restructuring the review process, the draft proposes codifying versions of the low volume exemption (LVE) and low releases and low exposures (LoREX) exemption.  EPA has long allowed these exemptions by rule, which ease section 5 requirements for eligible chemicals.  The draft would make certain PFAS ineligible for either exemption, and only allow other PFAS and persistent, bioaccumulative, and toxic chemicals (PBTs) to qualify if certain conditions were met.

Again, the draft does not specify the EPA review timeframe for these exemption submissions, which would differ for PFAS and PBTs.  Exemption timeframes when expedited via third-party assessment are also unspecified.

The draft would also establish a brand-new Section 5 exemption for de minimis quantities, allowing the manufacture or processing of any chemical in quantities of less than 500 kilograms per year if the manufacturer or processor notifies EPA within 30 days of commencing manufacture.  A variety of substances would be ineligible, including substances with at least one fully fluorinated atom, nanomaterials, and mercury, lead, and cadmium compounds, among others.

Other Section 5 Revisions

Another subtle but important change is the replacement of the term “may present” unreasonable risk with “is more likely than not to present” unreasonable risk in section 5.  Currently, if EPA determines that a new chemical or new use “may present” unreasonable risk in the absence of sufficient information to permit a reasoned evaluation, EPA must issue an order to address that risk.  Raising that bar to “more likely than not” would require greater certainty before issuance of an order, known as a 5(e) order.

Similarly, the draft proposes to change the standard for granting section 5 exemptions from “will not present” unreasonable risk to “is not likely to present” unreasonable risk.

The draft also addresses incomplete submissions.  Under the proposal, EPA would have a limited time to determine whether a submission is complete and issue a deficiency notice; its ability to do so after that window expires would be restricted.

Environmental groups and EPA have often pointed to incomplete section 5 submissions and associated rework as a significant contributor to new chemical delays.

Other provisions in the draft require EPA to maintain a program similar or identical to the Sustainable Futures Program and consider information voluntarily provided in submissions, including whether the chemical may reduce greenhouse gas emissions among other criteria.

Key Definitions

Cutting across each of these reforms are proposed revisions to two foundational TSCA terms that would have significant implications for both new and existing chemical regulation.

First, the draft would narrow the scope of “conditions of use,” which are the reasonably foreseeable chemical uses evaluated by EPA to determine whether restrictions on a chemical are necessary.  While preserving the existing definition, the draft would add the following qualifications to what circumstances are considered conditions of use by:

  • Excluding “merely hypothetical circumstances.”
  • Requiring that EPA “have a cognizable basis to foresee [a] condition of use”
  • Excluding uses that violate other federal laws as “not within the meaning of what is reasonably foreseen.”
  • If a submitter provides information demonstrating that “broadly applied and effective exposure control measures are routinely used,” it would create a “rebuttable presumption that the lack of such measures is not reasonably foreseen.”

Second, the draft proposes to add bounds to “unreasonable risk,” a crucial, currently undefined term that serves as the basis for regulation under TSCA.  The draft would exclude “risks that may arise from common, well-understood hazards, such as irritation, corrosion, flammability, unreactive dust, and other physical effects” from the meaning of unreasonable risk.  It would also clarify that the phrase “includes consideration of both the hazard of a substance and the quantity, frequency, and duration of the exposure to the environment.”

House Subcommittee to Hold Hearing on New TSCA Reform Bill

On January 22, 2026, at 2pm ET, the House Energy and Commerce Committee’s Environment Subcommittee will hold a hearing to examine newly released Toxic Substances Control Act (TSCA) reform legislation.

The hearing, titled “Chemicals in Commerce: Legislative Proposal to Modernize America’s Chemical Safety Law, Strengthen Critical Supply Chains, and Grow Domestic Manufacturing,” will focus on a discussion draft released on January 15, 2026.  No witnesses are currently listed on the hearing webpage.

The discussion draft would make structural changes to key provisions of the statute, including revisions to TSCA section 4 testing requirements, section 5 new chemical reviews, and section 6 reviews of existing chemicals.  It would also reauthorize EPA’s authority to collect fees from manufacturers, which is set to expire later this year.

“Targeted and measured reforms [to TSCA] will increase accountability, strengthen domestic manufacturing, and safeguard the health and safety of our communities,” said House Energy and Commerce Committee Chairman Brett Guthrie (R-KY-02) and Environment Subcommittee Chairman Gary Palmer (R-AL-06) in a joint statement.

“The legislation we’ll be discussing in this hearing would support these goals and help to ensure TSCA processes are working effectively to evaluate chemical safety and support American innovation,” they added.

A livestream of the hearing will be available online.

House Science Committee to Hold January 8 Hearing on Chemical Regulation

On January 8, 2026, at 10am ET, the House Committee on Science, Space, and Technology will hold a hearing entitled “Chemistry Competitiveness: Fueling Innovation and Streamlining Processes to Ensure Safety and Security.”

According to Inside EPA, the committee said in an announcement that the hearing will “examine the state of chemical research and development in the United States and how the regulatory environment affects progress.”  It comes after an October Senate Environment and Public Works Committee hearing on chemical regulation, which included substantial discussion regarding possible Toxic Substances Control Act (TSCA) reform.

The hearing will feature the following witnesses:

  • Charlotte Bertrand, Senior Director, Chemical Management, Regulatory Policy and Strategy, American Chemistry Council
  • Stan Meiburg, Former Acting Deputy Administrator, United States Environmental Protection Agency
  • Gwen Gross, Ph.D., Senior Technical Fellow, The Boeing Company
  • Keith Corkwell, Senior Vice President and President of Lubrizol Additives, The Lubrizol Corporation

A livestream of the hearing will be available on YouTube.

New Mexico to Hold Hearing on PFAS in Products Rulemaking

Beginning February 23, 2026, at 9am MT, the New Mexico Environmental Improvement Board (EIB) will hold a hybrid public hearing to consider the adoption of a proposed rule to implement the state’s PFAS in products law.  EIB is currently accepting public comments in advance of the hearing.

A previous post addressed the proposal’s novel PFAS labeling requirements, which would apply to all products with intentionally added PFAS beginning January 1, 2027.  In addition to labeling, the proposed rule implements statutory product prohibitions, establishes manufacturer reporting obligations, and outlines the process for manufacturers to obtain “currently unavoidable use” (CUU) designations from the New Mexico Environment Department (NMED).

Much of the proposed rule closely tracks the underlying statute, HB 212.  However, the statute merely authorized—rather than required—labeling requirements, and left the CUU framework unspecified.  The proposed rule fills in those gaps.

Product Bans

The proposed rule implements HB 212’s phased-in product bans.  Beginning January 1, 2027, New Mexico will prohibit the sale of the following products with intentionally added PFAS:

  • Cookware
  • Food packaging
  • Dental floss
  • Juvenile products
  • Firefighting foam

On January 1, 2028, the prohibition will expand to include:

  • Carpets or rugs
  • Fabric treatments
  • Feminine hygiene products
  • Textiles
  • Textile furnishings
  • Ski wax
  • Upholstered furniture

Finally, beginning in 2032, the prohibition will apply to all products except:

  • Products exempt from regulation under HB 212 (such as used products, medical devices, and veterinary products); and
  • Uses that EIB designates as CUUs.

Although HB 212 authorizes the EIB to add additional product categories to the 2027 and 2028 bans, the proposed rule limits prohibitions to those required by the statute.

Manufacturer Reporting Requirements

On or before January 1, 2027, HB 212 requires manufacturers that sell products containing intentionally added PFAS to submit the following information to NMED:

  • A brief description of the product;
  • The purpose of the PFAS in the product;
  • The amount of each PFAS in the product by exact quantity or concentration range;
  • Manufacturer and contact information; and
  • Any other information requested by NMED.

Manufacturers must update their submissions within 30 days of a significant change.  The proposed rule defines “significant change” as the intentional addition of a new PFAS, a 10% or greater increase in the concentration of PFAS, or a change in responsible official or contact information.

The proposed rule sets a fee of $2,500 for the initial report and $1,000 for each subsequent significant change report, with fees adjusted for inflation.  It also establishes procedures for requesting reporting deadline extensions or waivers where substantially equivalent information is already publicly available.

Under HB 212, reporting obligations do not apply to products that are statutorily exempt or that have received a CUU designation.

Currently Unavailable Uses (CUUs)

To avoid prohibition of a product containing intentionally added PFAS, the proposed rule would allow a manufacturer—or a group of manufacturers—to submit a proposal to NMED requesting a CUU designation.  A separate proposal would be required for each individual combination of product category and associated industrial sector.

CUU proposals would generally be due at least 12 months before the effective date of the applicable sales prohibition.  For products subject to the January 1, 2027 prohibition, however, CUU proposals submitted by October 31, 2026 would be deemed approved pending NMED review.

The proposed rule would require that CUU proposals include:

  • Identification of the specific PFAS intentionally added to the product;
  • A brief description of the product;
  • An explanation of why the PFAS use “is essential for health, safety or the functioning of society”;
  • A description of how the PFAS is essential to the product’s function;
  • A description of whether alternatives for the specific use of PFAS are available;
  • A list of applicable federal and state regulations governing the product due to its intentional use of PFAS, including any sales prohibitions;
  • If the product is prohibited or lacks a CUU determination in another jurisdiction, a list of comparable products that remain on the market in that jurisdiction;
  • Where similar products are available despite a comparable prohibition, a justification for why those products are not reasonably available alternatives or documentation demonstrating that they would not perform as intended in New Mexico;
  • Contact information; and
  • Any known or reasonably ascertainable information regarding the human health or environmental impacts of PFAS in the product.

Most of these categories include additional, detailed information requests.  For example, when identifying comparable regulatory programs in other jurisdictions, submitters must specify whether the prohibition is absolute or includes a CUU-like process and, if so, whether the submitter has applied under that program and the status of the application.

CUU designations would expire three years after approval unless a manufacturer submits a new CUU proposal.  The proposed rule establishes a $5,000 fee for an initial CUU application and a $2,500 fee for renewals, with fees adjusted for inflation.

For CUU proposals related to the 2027 prohibitions, NMED would issue final determinations by March 1, 2027.  A list of approved CUUs would be made available on NMED’s website.

Testing and Enforcement

HB 212 authorizes NMED to require manufacturers to test products if the department has reason to believe that a product contains intentionally added PFAS.  The proposed rule sets a threshold for PFAS of 100 parts per million (ppm).  If test results exceed that threshold, the manufacturer would be required to submit an initial report and, if the product is prohibited, notify distributors and retailers.

Manufacturers that violate HB 212 or its implementing regulations may be subject to civil penalties of up to $15,000.  NMED may also assess administrative costs incurred in enforcing the statute and rules for each day a violation occurs.

More information about HB 212, also known as the PFAS Protection Act, is available on NMED’s website.

Senate EPW Committee to Examine the Future of PFAS Cleanup and Disposal

On November 19, 2025, at 10am, the Senate Committee on Environment and Public Works (EPW) will hold a hearing to “Examine the Future of PFAS Cleanup and Disposal Policy.”

The hearing will include the following panelists:

  • Eric Gerstenberg, Co-CEO of Clean Harbors, an environmental and industrial services company
  • Leah Pilconis, General Counsel of Associated General Contractors of America
  • Kate R. Bowers, Supervisory Attorney at the Congressional Research Service

Clean Harbors conducted a PFAS incineration study in 2024 in conjunction with EPA and the Defense Department (DOD).  According to EPA, the incinerator’s tested PFAS destruction and removal efficiencies “ranged from 99.95 to 99.9999 percent.”

The study followed procedures outlined in EPA’s 2024 interim guidance on PFAS destruction and disposal, discussed in a previous post.  EPA must update this guidance as necessary and at least every three years.  The forthcoming hearing is likely to shape the direction of those updates.

EPW to Hold October 23 Hearing on Chemical Regulation

The Senate Committee on Environment and Public Works (EPW) will hold a hearing on chemical regulation this week, offering potential insight into Toxic Substances Control Act (TSCA) reform legislation reportedly being developed in the Senate.

The hearing, titled “Examining the Beneficial Use and Regulation of Chemicals,” is scheduled for 10:30am on October 23, 2025.  It will be convened by EPW’s Chemical Safety Subcommittee, which is chaired by Senator John Curtis (R-Utah).

According to EPW’s website, the hearing will include the following panelists:

  • Peter Huntsman, President and CEO of Huntsman Corporation, a chemical manufacturer.
  • Gwen Gross, Senior Technical Fellow at The Boeing Company.
  • Tracey Woodruff, Professor and Director of the Program on Reproductive Health and the Environment at the University of California, San Francisco. Dr. Woodruff previously worked as a scientist at EPA.

The hearing was originally scheduled for July but was postponed.

New Mexico to Hold Webinar on PFAS Labeling on September 25

On September 25, 2025, the New Mexico Environment Department (NMED) will hold an informational webinar on product labelling requirements for PFAS at 1pm MT (3pm ET).  To register, email NMED-PFAS@env.nm.gov.

Under HB212, enacted in April 2025, NMED is authorized to adopt rules requiring that manufacturers label products containing PFAS.  Earlier this month, New Mexico’s Environmental Secretary reportedly told lawmakers that NMED would soon release draft regulations to implement HB 212, including labeling requirements.

PFAS Restrictions and Reporting Under HB 212
  • Labeling authority: NMED may require PFAS labeling.
  • Phased bans: Restrictions on intentionally added PFAS begin in 2027, expand to more product types in 2028, and culminate in a ban on most products in 2032. Exemptions apply for certain products, such as medical devices, and for uses designated by NMED as “currently unavoidable.”
  • Reporting requirement: By January 1, 2027, manufacturers must report information on intentionally added PFAS, including purpose of use and amount (by CASRN).

More details are available on NMED’s PFAS webpage.

Verdant Law to Lead ACA Webinar on FTC’s “Made in the USA” Enforcement

Verdant Law is pleased to announce that Phil Moffat and Irene Hantman will lead an American Coatings Association (ACA) webinar on the FTC’s renewed focus on “Made in the USA” claims.  The session will be held on September 25, 2025, from 1–2pm ET.

Although the current Trump administration has generally adopted a deregulatory stance, “Made in the USA” claims have been a notable exception.  This past July, the FTC declared “Made in the USA Month” and announced stepped-up enforcement, including warning letters to major retailers such as Amazon and Walmart.

This webinar will provide insight to help attendees align marketing strategies with legal standards, avoid enforcement risks, and ensure “Made in the USA” claims are both effective and compliant.

Attendance is limited to, but free for, ACA members.  Register here.

Phil Moffat to Present at Chemical Watch Regulatory Summit North America 2025

Verdant Law is pleased to announce that Phil Moffat will speak at Chemical Watch’s Regulatory Summit North America 2025, which will take place September 15–18 in Alexandria, Virginia.

On September 15 at 11:50 am, Mr. Moffat will present on the Trump administration’s implementation of the Toxic Substances Control Act (TSCA) New Chemicals Program.  At 12:40 pm, Mr. Moffat will join an extended Q&A panel titled “Stakeholder perspectives on new chemical trends.”

Registration for the summit is open for both in-person and virtual attendance.

Update – September 16, 2025

Slides from Mr. Moffat’s presentation, “Balancing Innovation and Risk Management: TSCA’s New Chemical Review Process,” are now available here.

Irene Hantman to Present at Chemical Watch Summit in September

Verdant Law is pleased to announce that Irene Hantman will present on litigation over green marketing claims at Chemical Watch’s Regulatory Summit North America 2025.

Ms. Hantman’s September 18 presentation will cover noteworthy recent cases, including suits against manufacturers of everyday consumer products over alleged PFAS content.  The presentation will also discuss possible impacts from state-level PFAS disclosure laws, which may lead to a floodgate of new lawsuits.

Following the 3:05pm presentation, Ms. Hantman will be joined by other experts for a Q&A session.

The Regulatory Summit will be held in Alexandria, Virginia, from September 15–18.  Virtual attendance options are available.

Update – November 11, 2025

Slides from Ms. Hantman’s presentation, “Green Marketing Claims, PFAS, and Litigation,” are now available here.